www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES
PANDEMIC PREPAREDNESS FOR BUSINESSES
BIRD-FLU
|
High demand items. Secure yours now.
Tamiflu for your staff and families Don’t rely on Government and hospital supplies. There won't be enough. Secure your order here. Alpha Pro Tech N-95 Face Masks Don't get beaten to the post again, stocks won't last. Secure your order here. |
|
FREE Influenza Pandemic Preparedness email eCourse. Get Your Certificate! Join our free pandemic preparedness and planning email eCourse program. Leave your name and email and we’ll take you, one step at a time, through your pandemic preparedness activities, plus give you TWO eBooks on pandemic planning and response for the home. Get a certificate too! To learn more and enroll yourself please click here. |
A BASIC UNDERSTANDING
The following is a short explanation about what is Bird-Flu
and its likely affect on businesses. It is important to note that birdflu
is/will be a very human tragedy. It is people who will be directly affected by
it, not systems or infrastructure. That is of course until those systems and
infrastructure which need human intervention in order to keep operating do not
receive the intervention they need. If those maintenance personnel or operators
are unable to get to work then the systems and utilities which we rely on will
also start to fall over.
In order to help mitigate panic in the workforce is
important to ensure all staff have an adequate understanding of what we are up
against and so do not fall prey to the rumours and sensationalism that will
appear once things start to get serious. In SARS we saw unchecked panic grip
the workforce, and this resulted in some (unnecessarily) isolating themselves
for months. We do not want this to happen again and arming staff with the facts
is the only real way to alleviate the panic and knee-jerk reactions which are
inevitable from the ignorant.
2. Definitions
An epidemic is defined as an infectious illness that spreads
so quickly that the number of new cases rises in an exponential manner rather
than just increasing linearly. This means that during epidemics, the number of
new cases doesn’t just go up by ones or twos each day. During an epidemic, the
number of new cases doubles every few days.
A pandemic is an epidemic that spreads across the globe
affecting every continent rather than being confined to one geographic area.
One of the most important reasons for influenza's success as a human invader is
its infectivity. The infectivity of an organism is determined by how easily it
is transmitted from one person to another. Infecting agents that can cause
illness after a small exposure are more contagious than ones that requires a
larger exposure. Infectivity is increased when infection can be passed between
people without any direct contact. The most common way for flu to be
transmitted is by breathing air contaminated with the virus. Coughing is how
the virus gets into the air in the first place. Flu can also be transmitted by
direct contact with someone ill with the disease. This includes shaking their
hand or even touching something that the sick person previously touched. Under
the right conditions, flu can remain infectious for days outside of the human
body, living on surfaces like counter tops or doorknobs. Transfer of the virus
can occur when a susceptible person touches a contaminated surface.
3. Infectivity
After the virus is spread from one person to another, it can
infect the new person only if that person is susceptible or vulnerable to it.
With respect to influenza, virtually 100% of the human population is
susceptible to a new strain. However, fully half the susceptible patients who
contract the flu have no or few symptoms.
Influenza causes pandemics because it scores so highly in
all these causes of infectivity. These characteristics of influenza help
explain why this organism can quickly spread from one region of the globe to
another. Even during the relatively primitive travel conditions existing in
1918 it only took 6 weeks for epidemic influenza to spread from the
4. Waves of Infection
A further feature of influenza pandemics not well appreciated
generally is that they occur in waves. The 1918 Spanish flu (H1N1) was
associated with three waves while the 1958 Asian flu (H2N2) and 1968
While the typical flu season predictably occurs from
November through March, during pandemics, flu can vary from this script. The
first wave of the 1918 flu occurred in the spring of that year ending in March.
That flu was very severe by usual standards but the second wave beginning 6
months later in September was the most fatal. The third wave occurred during
the following winter/spring and was the mildest of all. It is of note that
pandemics end simply because all or most susceptible persons within the population
have contracted the infection and have either died or developed immunity.
5. Susceptible Age
Groups
During pandemics, a major difference compared with seasonal
flu that is the highest death rates are among the healthy 20 to 30 year old
adults. This is in contrast with the seasonal flu that strikes the very old,
the young, and the infirm the hardest. Of course, the usual victims of seasonal
flu are not spared during pandemics. On the contrary, death rates are much
higher for every age and risk group during pandemics compared with seasonal
flu. The point here is that the age 20 to 30 year group, usually immune to the
ravages of seasonal flu, experiences the highest death rates of any group
during pandemic years. Ironically, one possible explanation for this pandemic
observation may relate to the increased health and vigor of this group’s immune
system.
6. What Makes the
H5N1 Avian Flu so Fearsome?
The reason for the present state of alert among world health
authorities is the belief that we are witnessing the development of a 1918-type
major flu pandemic in Southeast Asia -a once in a 100-year major flu pandemic
-due to the emergence of a H5N1 Influenza virus type A.
On average there are two minor pandemics for every one major
pandemic. The minor pandemics are associated with lower clinical attack and
case fatality rates than in major pandemics. For instance, the 1958 pandemic
was associated with three times as many deaths than seen for seasonal flu but
during the 1968 flu pandemic, there were only a few more deaths than would be
expected. It has now been 37 years since the last flu pandemic, which suggests
we may be due for big one soon.
7. Mortality Rates
What makes avian influenza H5N1 so troubling to the medical
community? It is its stunning killing ability, a statistic known as the
lethality of the disease. The 1918 flu, like most pandemics, infected 40% to
50% of the world's population or approximately 640 million persons at the time.
If we assume that approximately 80 million people died during the 1918
influenza pandemic, this results in a case fatality rate of about 12.5% of
those infected. What is so worrisome to the influenza experts at the WHO is the
case fatality rate for humans that become infected with the strain presently
brewing in
Right now, the virus is confined mostly to birds but has
adapted to tigers and pigs. Almost all the humans infected have had contact
with infected birds during processing, cooking, eating, caring for them.
However, a few people are thought to have caught the Bird-Flu from close
contact with infected relatives. At time of print, this appears to be changing.
8. Person to Person
Spread
Close attention is being given for any sign that H5H1 avian
influenza has become more efficient in person-to-person spread, either from
mutation or from swapping genes with another flu variety in an infected person
or animal. When this event occurs, a development that influenza experts predict
is imminent, the new virus would gain the ability to quickly spread directly
from person-to-person. This development would signal the beginning of the
pandemic.
9. Pandemic
Characteristics
A Bird-Flu pandemic will not be like a physical disaster. A
pandemic has unique characteristics when compared with a more "typical"
disaster. For example:
The impact of a pandemic would likely
be widespread, not localised to a single area or region; therefore there may be
little outside assistance. Many business continuity plans (BCPs) assume some
part of an organisation is unaffected and can take up the required capacity.
A pandemic is not a physical
disaster. It has some unique characteristics that require implementation of
activities to limit contact such as restriction of movement, quarantine, and
closure of public gatherings.
A pandemic would not be a short,
sharp event leading immediately to commencement of a recovery phase. Many BCPs
assume the event is short/sharp and that recovery can start immediately.
It is quite likely that there will be
some advance warning from the development of the pandemic, but it is always
possible that any warning period may be very short. Should pandemic influenza
spread within SE Asia it will probably be some weeks before the full impact on
workforce will be felt, although there may be some early impacts resulting from
closures of schools and similar containment measures.
10. Absenteeism
Projections
Unlike natural disasters, where any disruption to business
service provision is likely to be hardware-related, disruption to business
operation in the event of a pandemic is anticipated to be mainly human-resource
oriented. WHO advises that businesses should plan for up to 50% staff absences
for periods of about two weeks at the height of a severe pandemic wave, and
lower levels of staff absence for a few weeks either side of the peak. Overall
a pandemic wave may last about 8 weeks. Note that the pandemic may come in
waves of varying severity over time.
10.1 Staff absences can be expected for many reasons:
10.2 Illness / incapacity (suspected / actual / post-infectious);
10.3 Some employees may need to stay at home to care for the ill;
10.4 People will feel safer at home (e.g. to keep out of crowded places such as public transport);
10.5 Some people may be fulfilling other voluntary emergency roles in the community; and
10.6 Others may need to stay at home to look after school-aged children (as schools are likely to be closed).
A pandemic could last many months and may contain peaks
followed by periods of reduced illness. The 50% is an estimate of staff
absences at peaks of a significant pandemic.
11. Supplies
A pandemic may have other impacts on businesses, for
example:
11.1 supplies of materials needed for
ongoing activity may be disrupted, e.g. if they are imported as air freight;
similarly, availability of services from sub-contractors may be impacted (this
may affect maintenance of key equipment, and is an area that merits close
planning attention); and
11.2 demand for services may be impacted - demand for some services may increase (internet access is a possible example);
while demand for others may fall (e.g. certain types of travel activity may
reduce).
12. Business
Continuity Plans
Business continuity plans may need to be reviewed to ensure
that they are robust to significant staff absences and other pandemic-related risks.
Know your company’s business continuity plans for dealing with the pandemic and
ensure those you are responsible for also know those plans.
Don’t rely on Government and hospital supplies. There won't be enough. Get yours here now.
More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Pandemic Response Manual. It has all of this and much, much more. To learn more about it and get some free stuff click here.
|

ONLINE'S OTHER TOPICS BELOW:
|
|
|
| 06/25/2009 05:00 PM |
| Preclinical Proof-of-Concept Studies Published For Novavax Seasonal Influenza Virus-Like-Particle Vaccine |
|
Novavax, Inc. (Nasdaq: NVAX) announced publication of the preclinical study results that supported the clinical development of the company's investigational VLP vaccine against the H3N2, H1N1 and B influenza strains. The study, which was conducted by scientists from the University of Pittsburgh, Center for Vaccine Research and Novavax, was published in the June 24, 2009 online issue of PLoS ONE.
|
| 06/05/2009 08:00 PM |
| A Closer Look At The I-Con™ - Isolation And Containment For Pandemic Control |
|
American Innovative Research (A.I.R.) cofounders, David Palmer and Judy Piscione, explain how the impact of the avian flu pandemic originally motivated their company's researching a home option of an isolation and containment unit. A.I.R. CEO Palmer states that he and Piscione leveraged decades of success in biomedical research and semiconductor clean-room technology to found American Innovative Research Corp. Palmer defines A.I.R.
|
| 06/05/2009 06:00 PM |
| Animal Production And Health To Be Addressed At FAO/IAEA Symposium |
|
An international symposium to be held in Vienna next week will focus on the use of nuclear technologies to enhance animal nutrition and reproduction strategies and to detect and control animal-origin diseases that can be transmitted to humans, such as swine and avian influenza. Around 500 animal production and health experts from over 100 countries will present up-to-date findings for solving or alleviating factors affecting animal production.
|
| 06/04/2009 04:00 PM |
| Indirect Transmission Can Trigger Influenza Outbreaks In Birds |
|
New data on the persistence of avian influenza viruses in the environment has allowed a team of University of Georgia researchers to create the first model that takes into account both direct and indirect transmission of the viruses among birds. The model, which is detailed in the early online edition of the journal Proceedings of the National Academy of Sciences, has the potential to shed new light on how outbreaks begin in wild bird populations.
|
| 06/02/2009 06:00 PM |
| News From The American Chemical Society, May 27, 2009 |
|
Bird flu virus remains infectious up to 600 days in municipal landfills Amid concerns about a pandemic of swine flu, researchers from Nebraska report for the first time that poultry carcasses infected with another threat - the "bird flu" virus - can remain infectious in municipal landfills for almost 2 years. Their report is scheduled for the June 15 issue of ACS' semi-monthly journal Environmental Science & Technology. Shannon L.
|
| 05/31/2009 04:00 PM |
| Bird Flu Virus Remains Infectious Up To 600 Days In Municipal Landfills |
|
Amid concerns about a pandemic of swine flu, researchers from Nebraska report for the first time that poultry carcasses infected with another threat - the "bird flu" virus - can remain infectious in municipal landfills for almost 2 years. Their report is scheduled for the June 15 issue of ACS' semi-monthly journal Environmental Science & Technology. Shannon L.
|
| 05/25/2009 04:00 PM |
| The Challenges Of Avian Influenza Virus: Mechanism, Epidemiology And Control |
|
The latest special issue of Science in China Series C: Life Sciences focuses on the recent progress in the H5N1-related research field. Early 2009, eight human infection cases of H5N1 highly pathogenic avian influenza (HPAI) virus, with 5 death cases, were reported in China. This again made the world alert on a possible pandemic worldwide, probably caused by avian-origin influenza virus.
|
| 05/25/2009 03:00 PM |
| Tighter Surveillance Of Swine Flu In Pigs Needed Worldwide Says CDC |
|
The US Centers for Disease Control and Prevention (CDC) said that there is a "global need for more systemic surveillance of influenza viruses in pigs", during a press briefing where they explained the findings of a recent study on the genetic and antigenetic properties of the new 2009 H1N1 swine flu virus.
|
| 05/20/2009 10:00 PM |
| In A New Way Of Treating The Flu, Both The H And N Portions Of The Virus Are Targeted |
|
What happens if the next big influenza mutation proves resistant to the available anti-viral drugs? This question is presenting itself right now to scientists and health officials this week at the World Health Assembly in Geneva, Switzerland, as they continue to do battle with H1N1, the so-called swine flu, and prepare for the next iteration of the ever-changing flu virus.
|
| 05/19/2009 09:00 PM |
| New Vaccine Strategy Might Offer Protection Against Pandemic Influenza Strains |
|
A novel vaccine strategy using virus-like particles (VLPs) could provide stronger and longer-lasting influenza vaccines with a significantly shorter development and production time than current ones, allowing public health authorities to react more quickly in the event of a potential pandemic. Ted Ross, Ph.D.
|
| 05/13/2009 08:00 PM |
| News From Burnham Institute For Medical Research, May 2009 |
|
Human monoclonal antibodies effective against bird and seasonal flu viruses Dr. Robert Liddington and colleagues, working with researchers at the Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention, reported the identification of human monoclonal antibodies that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses and some seasonal influenza viruses.
|
| 05/11/2009 06:00 PM |
| Bird Flu Research Could Help With Swine Flu Vaccine |
|
A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunov®, the Novartis investigational pre-pandemic avian influenza vaccine formulated with Novartis' proprietary MF59® adjuvant, can elicit a broadly cross-reactive immune response covering all known H5N1 antigenic variants, even when that booster dose is administered six years after the initial priming dose.
|
| 05/05/2009 11:00 PM |
| EFPIA Response To The A (H1N1) Novel Influenza Virus |
|
EFPIA is aware and concerned by the current outbreak of a novel influenza, which appears to have originated in Mexico. We note the WHO's decision to raise the level of influenza pandemic alert from the current phase 4 to phase 5. We will continue to monitor the situation closely, working with our colleagues at the International Federation of Pharmaceutical manufacturers and Associations.
|
| 05/02/2009 07:00 PM |
| Novartis Investigational Adjuvanted (MF59) Pre-pandemic Avian Influenza Vaccine Aflunov® Shows Long Lasting, cross-protective Immune Response |
|
A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunov®, the Novartis investigational pre-pandemic avian influenza vaccine formulated with Novartis' proprietary MF59® adjuvant, can elicit a broadly cross-reactive immune response covering all known H5N1 antigenic variants, even when that booster dose is administered six years after the initial priming dose.
|
| 04/30/2009 06:00 PM |
| Avian Flu Research Sheds Light On Swine Flu Outbreak |
|
A new study by University of Maryland researchers suggests that the potential for an avian influenza virus to cause a human flu pandemic is greater than previously thought. Results also illustrate how the current swine flu outbreak likely came about. As of now, avian flu viruses can infect humans who have contact with birds, but these viruses tend not to transmit easily between humans.
|
| 04/29/2009 03:00 PM |
| Is Swine Flu A Worldwide Threat? |
|
After human cases of a new H1N1 swine influenza A virus were first reported in Mexico and then quickly spread around the world, the World Health Organization (WHO) raised its pandemic alert level from phase 3 to phase 4, on April 27. The virus is a fusion of human, pig and avian influenza. There was growing international concern a week ago, after outbreaks of illnesses similar to influenza were reported in Mexico and in other countries.
|
| 04/29/2009 03:00 PM |
| Swine Flu Baffles Experts And Raises More Questions Than Answers |
|
As countries around the world ready themselves for the possibility of a global pandemic in the wake of increasing numbers of confirmed cases of people infected with a new strain of A/H1N1 influenza virus that is being described as swine flu, investigations digging deeper into the history and evidence surrounding the outbreak are coming up with more questions than answers.
|
| 04/28/2009 11:00 PM |
| NanoViricides, Inc. Says Flu-Cide Drug Designed To Destroy All Influenza A Viruses Including Swine And Bird Flu |
|
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.
|
| 04/28/2009 09:00 PM |
| Pandemic Flu Vaccine 6-Month Time Lag Warns Scientist |
|
New research published April 27 from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. By that time, the first wave of pandemic flu may be over before people are vaccinated, says Dr Iain Stephenson, Consultant in Infectious Diseases at the Leicester Royal Infirmary and a Clinical Senior Lecturer at the University of Leicester.
|
| 04/28/2009 06:00 PM |
| Scientist Warns Over Pandemic Flu Vaccine Six-month Time Lag |
|
New research published from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. By that time, the first wave of pandemic flu may be over before people are vaccinated, says Dr Iain Stephenson, Consultant in Infectious Diseases at the Leicester Royal Infirmary and a Clinical Senior Lecturer at the University of Leicester.
|









